Desomorphine
Desomorphine is a semi-synthetic opioid of the morphinan class, first synthesized in the early 1930s and marketed by Roche under the trade name Permonid.12 Characterized by a fast onset, short duration, and analgesic potency roughly ten times that of morphine,3 its significant dependence potential led to withdrawal from clinical use.1 It is the psychoactive component of the crude street preparation known as krokodil,45 notorious for causing severe tissue necrosis at injection sites due to toxic impurities.5
Contents
Dosage & Duration
Dosage
Duration
Subjective Effects
The experience is broadly comparable to that of heroin or oxycodone, dominated by euphoria, sedation, and powerful pain relief. Owing to its structural differences from morphine, the onset is notably rapid and the duration of action considerably shorter, producing a fast-arriving but relatively brief opioid state. At equianalgesic doses, respiratory depression is more severe than that of morphine.
Physical
The body experience combines heavy sedation and analgesia with characteristic opioid side effects, including constipation, nausea and vomiting, itching, urinary retention, and suppression of the drive to breathe. Pupil constriction, skin flushing, and pins-and-needles sensations (paresthesia) commonly accompany the experience, and drops in blood pressure have been noted.
Cognitive
The headspace centers on opioid euphoria alongside a sedated, pain-free mental state. Decreased libido is also reported.
Reagent Testing
Loading reagent data
Pharmacology
Pharmacodynamics
Desomorphine acts as a potent agonist at the μ-opioid receptor, functionally mimicking the activity of endogenous endorphins. It is approximately 8 to 10 times more potent than morphine on a milligram-per-milligram basis via intravenous or intramuscular administration.3 The detailed pharmacological characterization of desomorphine remains incomplete.
Pharmacokinetics
Detailed pharmacokinetic data for desomorphine is limited.6 No specific information regarding metabolic enzymes, metabolic pathways, or bioavailability has been characterized in the available literature. Desomorphine has a pKa of 9.69 and exists in four isoforms (A, B, C, and D), with the C and D forms appearing to be the more commonly studied.
Dangerous
Highest riskThese combinations are considered extremely harmful and should always be avoided. Reactions to these drugs taken in combination are highly unpredictable and have a potential to cause death.
Unsafe
AvoidThere is considerable risk of physical harm when taking these combinations, they should be avoided where possible.
Caution
Use cautionThese combinations are not usually physically harmful, but may produce undesirable effects, such as physical discomfort or overstimulation. Extreme use may cause physical health issues. Synergistic effects may be unpredictable. Care should be taken when choosing to use this combination.
Tolerance
All other opioids
Harm Potential
Addiction & Dependence
Psychological
Extremely HighDemonstrates significantly higher abuse potential than morphine in human use, with compulsive redosing patterns similar to heroin.7 The rapid onset produces an intense euphoric rush that reinforces addictive behavior. Animal studies showed limited addiction liability, but real-world use patterns indicate extremely high psychological addiction potential.
Physical
HighPhysical dependence develops with repeated administration, requiring increasing doses to achieve desired effects. Withdrawal syndrome occurs upon cessation.2 Animal studies in monkeys showed less severe tolerance and withdrawal compared to morphine, though human patterns indicate significant physical dependence typical of potent opioids.
Toxicity
Pure desomorphine produces more severe respiratory depression than morphine at equianalgesic doses, making this the primary mechanism of fatal overdose.2
Illicit krokodil use is associated with bone infection (osteomyelitis), cartilage damage, and muscle destruction; these effects stem from toxic synthesis contaminants rather than desomorphine itself.8
Liver damage has been reported in users of illicitly manufactured krokodil, attributed to toxic synthesis contaminants rather than desomorphine itself.8
Kidney damage has been reported in users of illicitly manufactured krokodil, attributed to toxic contaminants rather than desomorphine itself.8
Iodine used in illicit synthesis can cause thyroid damage in users of contaminated krokodil.8
Brain damage has been reported among users of illicitly manufactured krokodil, attributed to toxic contaminants; pure desomorphine causes sedation but no documented long-term neurotoxicity.8
Urinary retention is a recognized side effect at clinical doses and was considered a significant adverse effect limiting therapeutic use.
Seizure Risk
Seizures are listed among serious medical complications but are not a primary concern or commonly reported adverse effect with desomorphine use.
History & Culture
Discovery and Early Development
Desomorphine was first discovered and patented in Germany in 1920 by researchers working for the pharmaceutical company Knoll, though this early work did not gain widespread recognition. The compound was independently synthesized in the United States in 1932 by chemist Lyndon Frederick Small, who…
Legality
International
Single Convention on Narcotic Drugs 1961
By Country
References
Source Pages
Citations
- (May 2014). A "krokodil" emerges from the murky waters of addiction. Abuse trends of an old drug. Life Sciences, 102(2), 81–87. https://doi.org/10.1016/j.lfs.2014.03.00812
- (April 2017). Desomorphine (Krokodil): An overview of its chemistry, pharmacology, metabolism, toxicology and analysis. Drug and Alcohol Dependence, 173, 59–68. https://doi.org/10.1016/j.drugalcdep.2016.12.021123
- (December 2020). DARK Classics in Chemical Neuroscience: Krokodil. ACS Chemical Neuroscience, 11(23), 3968–3978. https://doi.org/10.1021/acschemneuro.0c0049512
- (2012). Desomorphine goes "crocodile". Journal of Addictive Diseases, 31(4), 407–412. https://doi.org/10.1080/10550887.2012.735570123
- (April 2015). The harmful chemistry behind krokodil (desomorphine) synthesis and mechanisms of toxicity. Forensic Science International, 249, 207–213. https://doi.org/10.1016/j.forsciint.2015.02.00112345
- (August 2018). In vitro metabolism of desomorphine. Forensic Science International, 289, 140–149. https://doi.org/10.1016/j.forsciint.2018.05.0171
- (July 2013). Breaking worse: the emergence of krokodil and excessive injuries among people who inject drugs in Eurasia. The International Journal on Drug Policy, 24(4), 265–274. https://doi.org/10.1016/j.drugpo.2013.04.0071
- (March 2016). A new drug with a nasty bite: A case of krokodil-induced skin necrosis in an intravenous drug user. JAAD Case Reports, 2(2), 174–176. https://doi.org/10.1016/j.jdcr.2016.02.007123456
- (n.d.). Morphine derivative and processes for its preparation. https://patents.google.com/patent/US1980972A/en12
- (September 2014). Internet search and krokodil in the Russian Federation: an infoveillance study. Journal of Medical Internet Research, 16(9), e212. https://doi.org/10.2196/jmir.32031
- (n.d.). Betäubungsmittelgesetz (BtMG) Anlage I — nicht verkehrsfähige Betäubungsmittel. Bundesministerium der Justiz / gesetze-im-internet.de. https://www.gesetze-im-internet.de/btmg_1981/anlage_i.html1
- (n.d.). Постановление Правительства РФ от 30.06.1998 N 681 — Перечень наркотических средств, психотропных веществ и их прекурсоров, подлежащих контролю в Российской Федерации (Список I). Government of the Russian Federation. https://legalacts.ru/doc/postanovlenie-pravitelstva-rf-ot-30061998-n-681/1
- (n.d.). Verordnung des EDI über die Verzeichnisse der Betäubungsmittel (BetmVV-EDI, SR 812.121.11) — Verzeichnis a. Eidgenössisches Departement des Innern / fedlex.admin.ch. https://www.fedlex.admin.ch/eli/cc/2011/363/de1
- (n.d.). 21 CFR § 1308.11 Schedule I — Opium derivatives (desomorphine, drug no. 9055). U.S. Government Publishing Office / govinfo.gov. https://www.govinfo.gov/content/pkg/CFR-2019-title21-vol9/xml/CFR-2019-title21-vol9-part1308.xml1
Further Reading
Automated synthesisInformation aggregated and synthesized using an autonomous workflow built by Josie Kins.
Suggest an edit
Spotted a mistake, an outdated claim, or something missing from the Desomorphine article? Send the editors a private note. Feedback lands in a moderation queue and is never shown on the site.